Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas N Vahanian

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|January 16, 2003
Herpes simplex amplicon vectorsCharles J Link, Nicholas N Vahanian, Suming Wang
Immunotherapy|January 21, 2016
Algenpantucel-L immunotherapy in pancreatic adenocarcinomaAndrew L Coveler, Gabriela R Rossi, Nicholas N Vahanian, et al.
Human Vaccines & Immunotherapeutics|December 1, 2015
Pancreatic cancer: Update on immunotherapies and algenpantucel-LKinsey A McCormick, Andrew L Coveler, Gabriela R Rossi, et al.
Oncoimmunology|December 25, 2012
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophanRichard Metz, Sonja Rust, James B Duhadaway, et al.
Ochsner Journal|June 19, 2014
Combination immunotherapy for high-risk resected and metastatic melanoma patientsAdam I Riker, Gabriela R Rossi, Prerna Masih, et al.
Plos One|August 9, 2017
Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responsesWenlan Alex Chen, Jinjin Zhang, Katie M Hall, et al.
Stem Cells (Dayton, Ohio)|November 3, 2007
Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD miceLarissa Verda, Duck An Kim, Susumu Ikehara, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigensGeorge P Hemstreet, Gabriela R Rossi, Vladimir M Pisarev, et al.
Oncotarget|October 21, 2014
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsHatem H Soliman, Erica Jackson, Tony Neuger, et al.
Virology|November 26, 2009
A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengeRobert B Mandell, Ramesh Koukuntla, Laura J K Mogler, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|January 16, 2003
Herpes simplex amplicon vectorsCharles J Link, Nicholas N Vahanian, Suming Wang
Immunotherapy|January 21, 2016
Algenpantucel-L immunotherapy in pancreatic adenocarcinomaAndrew L Coveler, Gabriela R Rossi, Nicholas N Vahanian, et al.
Human Vaccines & Immunotherapeutics|December 1, 2015
Pancreatic cancer: Update on immunotherapies and algenpantucel-LKinsey A McCormick, Andrew L Coveler, Gabriela R Rossi, et al.
Oncoimmunology|December 25, 2012
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophanRichard Metz, Sonja Rust, James B Duhadaway, et al.
Ochsner Journal|June 19, 2014
Combination immunotherapy for high-risk resected and metastatic melanoma patientsAdam I Riker, Gabriela R Rossi, Prerna Masih, et al.
Plos One|August 9, 2017
Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responsesWenlan Alex Chen, Jinjin Zhang, Katie M Hall, et al.
Stem Cells (Dayton, Ohio)|November 3, 2007
Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD miceLarissa Verda, Duck An Kim, Susumu Ikehara, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigensGeorge P Hemstreet, Gabriela R Rossi, Vladimir M Pisarev, et al.
Oncotarget|October 21, 2014
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsHatem H Soliman, Erica Jackson, Tony Neuger, et al.
Virology|November 26, 2009
A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengeRobert B Mandell, Ramesh Koukuntla, Laura J K Mogler, et al.
Pageof 2